The Global Sleep Apnea Device Market is Forecast to Record a Value of US$9.29 Billion in 2024, Growing at a CAGR of 7.94% Between 2020-2024

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The "Global Sleep Apnea Therapeutic & Diagnostic Devices Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Factors such as the expansion of medical devices, rising prevalence of obstructive sleep apnea (OSA), growth in the geriatric population, increasing medical technology R&D spending and rise in obesity are set to drive growth of the global sleep apnea device market. However, the market growth will be challenged by the high cost of CPAP, side effects associated with CPAP and stringent regulations. A few notable trends may include, rising investment in Artificial Intelligence (AI) startups, increasing focus on Telehealth, development of Hypoglossal Nerve Stimulation (HNS) and rising adoption of actigraphy diagnostic devices.

The global sleep apnea market has emerged out as very strong because of the rising number of sleep apnea cases across the world. The market is covered with a wide range of diagnostic as well as therapeutic devices. Positive Airway Pressure (PAP) devices are the widely used therapeutic method in the sleep apnea space because of the highly effective results. Rising awareness about sleep apnea and related comorbidities among people is playing a significant role in persuading people to undergo diagnosis as well as treatment therapies.

The fastest-growing regional market was North America with the highest incidence of obstructive sleep apnea cases. The U.S. has accounted for the highest share in the North America market due to the technological advances in mask designs, improved designs of CPAP and enhanced support services for PAP. Further, Europe has also evolved out as a prominent market with an increased pool of untreated sleep apnea patients. Both the regions have considerable growth potentials that would help in the expansion of the global sleep apnea market in coming years.

Scope of the report:

• The report provides a comprehensive analysis of the global sleep apnea therapeutic & diagnostic devices market.
• The major regional markets (North America, Europe, Asia-Pacific and ROW), along with the country coverage of the U.S., Germany and the U.K. have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Koninklijke Philips, ResMed, Invacare Corporation, Fisher & Paykel, Somnomed Ltd. and BMC Medical) are also presented in detail.

Key Topics Covered:

1. Overview
1.1 Introduction
1.2 Risk Factors For Sleep Apnea
1.3 Types of Sleep Apnea
1.4 Diagnosis and Treatment of Sleep Apnea
1.5 Sleep Apnea Devices
1.6 Continuous Positive Airway Pressure (CPAP)

2. Impact of COVID-19
2.1 Rise in Number of COVID-19 Cases
2.2 Growth in Government Spending on Healthcare
2.3 Acceleration in Healthcare Internet of Thing (IoT)
2.4 Regional Impact

3. Global Market Analysis
3.1 Global Sleep Apnea Device Market by Value
3.2 Global Sleep Apnea Device Market Forecast by Value
3.3 Global Sleep Apnea Device Market by Type
3.3.1 Global Therapeutic Sleep Apnea Device Market by Value
3.3.2 Global Therapeutic Sleep Apnea Device Market Forecast by Value
3.3.3 Global Diagnostic Sleep Apnea Device Market by Value
3.3.4 Global Diagnostic Sleep Apnea Device Market Forecast by Value
3.3.5 Global Diagnostic Sleep Apnea Device Market by Device Type
3.3.6 Global Polysomnography (PSG) device Market Forecast by Value
3.4 Global Sleep Apnea Device Market by Region

4. Regional Market Analysis
4.1 North America
4.2 Europe
4.3 Asia-Pacific
4.4 ROW

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Expansion of Medical Device
5.1.2 Rising Prevalence of Obstructive Sleep Apnea (OSA)
5.1.3 Growth in Geriatric Population
5.1.4 Increasing Medical Technology R&D Spending
5.1.5 Rise in Obesity
5.1.6 Rapid Urbanization
5.1.7 Upsurge in Healthcare Expenditures
5.1.8 Growing Awareness about Sleep Apnea and Related Comorbidities
5.2 Key Trends and Developments
5.2.1 Rising Investment in Artificial Intelligence (AI) Startups
5.2.2 Increasing Focus on Telehealth
5.2.3 Development of Hypoglossal Nerve Stimulation (HNS)
5.2.4 Rising Adoption of Actigraphy Diagnostic Devices
5.3 Challenges
5.3.1 High Cost of Continuous Positive Airway Pressure (CPAP) Machines
5.3.2 Side Effects Associated with CPAP Therapy
5.3.3 Stringent Government Regulations

6. Competitive Landscape
6.1 Global Market
6.1.1 Key Players - Revenue Comparison
6.1.2 Key Players - R&D Expenditure Comparison
6.1.3 Key Players - Market Capitalization Comparison
6.1.4 Key Players - Sleep Apnea Product Portfolio

7. Company Profiles

• BMC Medical
• Fisher & Paykel
• Invacare Corporation
• Koninklijke Philips
• ResMed
• Somnomed Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/gmeq6u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood | +353-1-481-1716 | press@researchandmarkets.net

View original content:http://www.prnewswire.com/news-releases/the-global-sleep-apnea-device-market-is-forecast-to-record-a-value-of-us9-29-billion-in-2024--growing-at-a-cagr-of-7-94-between-2020-2024--301134002.html

SOURCE Research and Markets